Wellbert Pharmaceuticals (Bombay) Pvt Ltd
About Wellbert Pharmaceuticals (Bombay) Pvt Ltd
Data last updated:
Wellbert Pharmaceuticals (Bombay) Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 November 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33110MH1985PTC038128. The company has 3 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹18 Lakh. It is led by directors Mithilesh Mani Tripathi and Bhupesh Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office is at Bhanydas Mhatre House Oppanita Soc Dahisar (W), Mumbai, Maharashtra, India – 400068.
As per the financials filed for FY 2017, the company reported a revenue of ₹3.81 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹14.21 Lakh (net margin 3.7%) and EBITDA of ₹32.39 Lakh (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.
As per MCA filings, the company has open charges of ₹24 Cr on record. Court records list 32 cases involving the company, including 13 filed by the company and 19 filed against it; 2 cases are pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Wellbert Pharmaceuticals (Bombay) Pvt Ltd's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBhanydas Mhatre House Oppanita Soc Dahisar (W), Mumbai, Maharashtra, India – 400068
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wellbert Pharmaceuticals (Bombay) Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wellbert Pharmaceuticals (Bombay) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Wellbert Pharmaceuticals (Bombay) Pvt Ltd, buy the company report.
Financials of Wellbert Pharmaceuticals (Bombay) Pvt Ltd
FY 2017 filings availableWellbert Pharmaceuticals (Bombay) Pvt Ltd reported revenue of ₹3.81 Cr (up 45% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over three years, including 45% growth in the latest year. EBITDA rose 219% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹3.81 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹32.39 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹14.21 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 8.5% | ||
| Net Profit Margin | 3.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Wellbert Pharmaceuticals (Bombay) Pvt Ltd, buy the company report.
Board of directors of Wellbert Pharmaceuticals (Bombay) Pvt Ltd
Wellbert Pharmaceuticals (Bombay) has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mithilesh Mani Tripathi | Director | 23 Nov 1985 | 40 Years 11 Months | Current |
| Bhupesh Tripathi | Director | 21 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Wellbert Pharmaceuticals (Bombay) Pvt Ltd is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alive Lifescience Private Limited | ₹3.83 Cr (FY 2025) | 3.0% | Ahmedabad, Gujarat, India | |||
| Dharuhera Pharmaceuticals Pvt Ltd | ₹3.83 Cr (FY 2025) | -79.0% | New Delhi, Delhi, India | |||
| Alentica Pharmaceuticals Private Limited | ₹3.83 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| Wellbert Pharmaceuticals (Bombay) Pvt Ltdthis company | ₹3.81 Cr (FY 2017) | ₹14.21 Lakh | 3.7% | 45.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Wellbert Pharmaceuticals (Bombay) Pvt Ltd, buy the company report.
Auditor
Wellbert Pharmaceuticals (Bombay) Pvt Ltd is audited by G S DOOT & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G S DOOT & CO | FY 2017 | 102686W |
Shareholding
The shareholding of Wellbert Pharmaceuticals (Bombay) Pvt Ltd is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Wellbert Pharmaceuticals (Bombay) Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Jan 2016 | 10614082 | The Bharat Co-Operative Bank(Mumbai) Ltd | ₹1 Cr | Open | |
| 04 Jan 2016 | 10614085 | The Bharat Co-Operative Bank(Mumbai) Ltd | ₹9 Cr | Open | |
| 04 Jan 2016 | 10616155 | The Bharat Co-Operative Bank(Mumbai) Ltd | ₹10 Cr | Open | |
| 12 Dec 2008 | 10136837 | State Bank of India | ₹4 Cr | Open |
To see the full charge records of Wellbert Pharmaceuticals (Bombay) Pvt Ltd, buy the company report.
Total charge records: 4 View all charges
Legal cases
Wellbert Pharmaceuticals (Bombay) Pvt Ltd has 32 court cases on record: 13 filed by Wellbert Pharmaceuticals (Bombay), 19 filed against it. 2 cases are pending and 30 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 18 | 2 |
| High courts | 9 | 1 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 32)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed against the company by Oorja Corporate Advisors Pvt. Ltd. | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Anchor Mark Pvt. Ltd. | Disposed |
| Bombay High Court | Court case (COMSS) | Filed by the company against Amon Engineers Pvt Ltd | Disposed |
| District court, Silvassa, DNH at Silvasa | Court case (Spl. C. S.) | Filed by the company against Amon Engineers Pvt.Ltd. | Disposed |
| District court, Silvassa, DNH at Silvasa | Court case (Spl. C. S.) | Filed by the company against Ms Anchor Mark Pvt Ltd | Disposed |
To see the full case history of Wellbert Pharmaceuticals (Bombay) Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wellbert Pharmaceuticals (Bombay) Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wellbert Pharmaceuticals (Bombay) has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Wellbert Pharmaceuticals (Bombay) Pvt Ltd, buy the company report.
Recent activity
Wellbert Pharmaceuticals (Bombay) Pvt Ltd has 5 board changes on record since 1985: 2 appointments and 3 cessations. The latest: Bhupesh Tripathi was appointed as Director on 21 Apr 2023.
1 earlier event is in the company report.
Frequently asked questions
Wellbert Pharmaceuticals (Bombay) is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 November 1985 (41+ years old) and is registered under CIN U33110MH1985PTC038128.
Wellbert Pharmaceuticals (Bombay) has 2 current directors:
- Mithilesh Mani Tripathi - Director
- Bhupesh Tripathi - Director
The latest financial statements of Wellbert Pharmaceuticals (Bombay) on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
No. Wellbert Pharmaceuticals (Bombay) has 3 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Wellbert Pharmaceuticals (Bombay) is U33110MH1985PTC038128. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wellbert Pharmaceuticals (Bombay) has 32 court cases on record: 13 filed by the company and 19 filed against it. 2 are pending. Most are in the district courts.
Wellbert Pharmaceuticals (Bombay) was incorporated on 21 November 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Wellbert Pharmaceuticals (Bombay) by revenue are Alive Lifescience Private Limited, Dharuhera Pharmaceuticals Pvt Ltd, Alentica Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhupesh Tripathi was appointed as Director on 21 Apr 2023. Satyendra Kumar Mishra ceased to be Director on 21 Apr 2023. Surya Narain Tripathi ceased to be Director on 16 Apr 2021. Wellbert Pharmaceuticals (Bombay) has 5 board changes on record in total.
The registered office of Wellbert Pharmaceuticals (Bombay) is at Bhanydas Mhatre House Oppanita Soc Dahisar W, Mumbai, Maharashtra, India – 400068.
Wellbert Pharmaceuticals (Bombay) operates in the pharma industry, in the drug formulation and development segment.